Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tangningtongluo Tablet in People With Prediabetes : a Multicenter, Randomized, Double-blind, Placebo-controlled Trial

NCT05126251 is registered in ClinicalTrials.gov with Beijing University of Chinese Medicine as lead sponsor.

NCT NCT05126251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05126251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tangningtongluo Tablet in People With Prediabetes : a Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Beijing University of Chinese Medicine
Phase
Phase 2
Overall status
Unknown status
Start date
December 13, 2021
Completion date
June 30, 2023
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prediabetes